Agoracom Blog Home

Posts Tagged ‘Stillcanna’

Discovering the Benefits of CBD Oil SPONSOR: Mota Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 2:25 PM on Wednesday, April 29th, 2020

SPONSOR: Mota is seeking to become a vertically integrated global CBD brand. Mota is creating sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota. Combined total sales of almost $29,000,000 with a EBITDA of approximately 12.5% (2019) . Click Here for More Info

Mota large

CBD oil is increasingly acclaimed for its benefits. Use as an e-liquid for vaping, but also as a dietary supplement to fight against stress or depression, CBD is everywhere.

Find out what its benefits are, how to consume it, and where to find it.

With some of the best online suppliers in Europe, British users can now easily find and order CBD flowers in UK. It has simplified the way to purchase high-quality CBD online, and we can now enjoy the best CBD oils.

What is CBD oil?

CBD, or cannabidiol, is part of the family of cannabinoids, a group of molecules found in the hemp plant, such as THC or CBD. We all have so-called cannabinoid receptors in our brains, which explains why these compounds have a more or less significant impact on the human nervous system.

CBD oil is extracted from the cannabis plant. It contains mostly cannabidiol, the concentration of which varies depending on the product. Today it is mainly used as an e-liquid for electronic cigarettes, as CBD oil to add in food and drinks, and CBD capsules.

While the hemp plant has been cultivated for over 6.000 years in China, it is only today that CBD oil is becoming more and more popular, as scientists discover many benefits for our organism. Indeed, unlike THC, another cannabinoid, CBD does not have psychotropic properties. For this reason, cannabidiol is also called “therapeutic cannabis”!

What are the effects of CBD oil?

Unlike THC, the effects of CBD oil are not harmful to our nervous system. CBD does not cause a feeling of intoxication or euphoria, unlike THC, and therefore no loss of control.

Conversely, it offers a feeling of serenity and a sense of relaxation. CBD is also found in recognized drugs like Cannador, Sativex, or Epidiolex.

To start with, CBD oil can help you fall asleep. If it does not have the effect of a sleeping pill, it will, however, cause your body to relax to promote falling asleep indirectly.

Likewise, CBD oil can help you not only to combat stress but also to regulate your mood. Indeed, CBD acts in particular on receptors linked to anxiety. For this reason, it is reputed to be a powerful anxiolytic and is effective in treating depression.

Note that paradoxically, CBD oil can help you fight against drug addiction since it will promote emotional balance while helping you overcome anxiety and stress, often overwhelming during withdrawal.

Finally, CBD oil can be used as an anti-inflammatory, especially in the case of Crohn’s disease, a chronic inflammatory disease of the digestive system.

How should you use CBD oil?

CBD oil is consumed orally, by placing 1 to 2 drops on your tongue or by adding them to your food or drink. The bottles sold are therefore often equipped with a pipette. After swallowing the CBD oil drops, leave it on for 30 seconds before continuing to eat or keep busy.

Please note, it is essential not to exceed 3 doses per day. If you take too much CBD oil, you risk increasing the relaxing effects and wanting to sleep! The ideal is to start with a low dosage and increase it gradually if you support it.

Also, CBD oil is not recommended for pregnant women.

Is CBD oil legal in the UK?

Cannabis derivatives do not have an outstanding reputation, in particular, because of THC, the compound which has psychotropic effects. European legislation is therefore relatively strict with cannabidiol. For example, any product containing THC is prohibited if the THC level exceeds 0.2 %.

However, products from Cannabis sativa seeds and stems are not prohibited in the UK, which explains why most of the CBD oils currently on sale come from them. Despite everything, CBD oil remains banned for minors. No law has been enacted regarding CBD oil, but case law prevails until European law issues an opinion on the subject, not always in a pleasant manner!

Where to buy CBD oil?

CBD-based products are very numerous: crystals (the purest form) for culinary preparations or other uses of this type, oil, e-liquid for electronic cigarettes, CBD flowers, CBD resins, etc. You will, therefore, have no harm to find CBD for your consumption.

On the Internet, you will mainly find CBD oil, as on the online store. You will find a whole lot of websites that are claiming to sell the best CBD products. However, you should only buy the best quality of CBD flowers and CBD oils.

Check websites such as Justbob.shop to find the right CBD products. As a leading company in Europe, this supplier from Italy is offering natural CBD flowers and great CBD oils. Also, they are following a set of many quality controls, and they are recognized by the Italian authorities, which means that they are well-known and that they are complying with local and European laws.

Source: London Loves Business

MOTA Ventures $MOTA.ca Generates $4.29 Million in Revenue During March 2020 $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 9:23 AM on Monday, April 20th, 2020
Mota large
  • Generated CAN$4,290,000 with related expenses of $4,240,000
  • The Immune Support product line experienced further positive growth contributing to First Class acquiring 20,959 new customers during the month of March

VANCOUVER, BC / ACCESSWIRE / April 18, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company“) is excited to announce that for the month of March 2020, its First Class CBD brand achieved sales of Cdn$4,290,000, with related expenses of Cdn$4,240,000. Customer acquisition expenses for March 2020 include one-time costs of approximately Cdn$1,160,000 associated with the introduction of the new line of Immune Support and CBD products. The Immune Support product line experienced further positive growth contributing to First Class acquiring 20,959 new customers during the month of March. The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. The Company also launched an Immune CBD oil, along with an Elderberry Gummy product. The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Sales for March 2020 compare to sales of Cdn$1,280,000 during the same period last year, representing an increase of 235%.

The Company also introduced a new brand, Nature’s Exclusive CBD, in the first week of April 2020. The Nature’s Exclusive CBD brand will offer a range of products, which include the new Immune CBD oil, Elderberry gummies, CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.

First Class offers a CBD hemp-oil formulation intended to provide users with therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. First Class offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee. First Class plans to continue its significant growth in their U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am extremely pleased with the performance of our business during March 2020, a month where the world and the economy faced immeasurable challenges. Our ability to efficiently innovate and launch new products, is a perfect example of our primary competitive advantage, and what allows us to be a leader in the ecommerce space. We expect our investment in accelerated customer acquisition from February to March, including a one-time cost of Cdn$1,160,000, will continue to produce significant revenue growth, and are hopeful it will lead to increased profitability in the upcoming months,” stated Ryan Hoggan, CEO of the Company.

The Company cautions that figures for revenue, expenses and margin generated from the sale of First Class CBD products have not been audited, and are based on calculations prepared by management. Actual results may differ from those reported in this release once these figures have been audited. These figures were translated from US dollars into Canadian dollars using the Bank of Canada monthly average exchange rate of US$1.00:Cdn$1.3953 for March 2020 and US$1.00:Cdn$1.3368 for March 2019.

About Mota Ventures Corp.

Mota is an established ecommerce, direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the Company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Mota Ventures $MOTA.ca Announces Record Number of Subscriptions Year-To-Date in March and Over 6,000 New Customers in April $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 7:38 AM on Tuesday, April 14th, 2020
Mota large
  • First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th.
  • 1,700 of the new customers purchased products from the Immune Support line.
  • MOTA experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

VANCOUVER, BC / ACCESSWIRE / April 14, 2020 / Mota Ventures Corp. (CSE:MOTA FSE:1WZ:GR OTC PINK:PEMTF) (the “Company“) is excited to announce its First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th. Additionally, during this time period over 1,700 of the new customers purchased products from the Immune Support line. During the month of March, the Company experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

The Immunity Blend is currently the Company’s top seller in the Immune Support line. The all-natural blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. The line also features Immune CBD oil containing CBD, B3, B12, Vitamin C and Zinc and Immunity Gummy Bears contain 100% natural Elderberry extract.

First Class and Nature’s Exclusive offer a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. First Class and Nature’s Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee. The Company plans to continue its significant growth in U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am pleased at the incredible number of monthly subscriptions acquired during the month of March. We continue to see overwhelming interest in our Immune Support products and higher CBD content oils. We operate a very responsive and agile business, which allows us to identify consumer trends and execute upon the demand we are seeing in the marketplace,” stated Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Mota Ventures $MOTA.ca Acquires Interest in Folium Life Sciences $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 8:25 AM on Wednesday, April 8th, 2020
Mota large
  • Folium is a Health Canada licensed cannabis cultivator with facilities located on Vancouver Island.
  • Folium is nearing completion of the expansion of its existing cultivation facility, a further phase 2 expansion of the facility is expected.

VANCOUVER, BC / April 8, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTCPINK:PEMTF) (the “Company“) is pleased to announce that it has acquired (the “Acquisition“) all of the outstanding share capital of 1244780 B.C. Ltd. (the “Target“). The Acquisition was completed pursuant to a share exchange agreement (the “Purchase Agreement“), dated April 7, 2020, and entered into with an arms-length third-party (the “Vendor“). The sole asset of the Target consists of a 20% equity interest in Folium Life Sciences Inc. (“Folium“), which is in the process of developing a licensed indoor cannabis production facility located on Vancouver Island. In consideration for the Acquisition, the Company has issued 21,000,000 common shares.

Folium is a Health Canada licensed cannabis cultivator with facilities located on Vancouver Island. Folium is nearing completion of the expansion of its existing cultivation facility. Its business plan calls for a further phase 2 expansion of the facility. Folium aims to produce a high quality and consistent cannabis product through its facilities.

“Canada has been a pioneer in legalization and early adoption of cannabis for both recreational and medical purposes. This equity position in a well-capitalized licensed producer provides Mota with a sound financial investment in the sector.” stated Ryan Hoggan, CEO of the Company.

Each of the Vendor, the Target, and Folium are at arms-length from the Company. The Acquisition does not constitute a fundamental change for the Company, nor has it resulted in a change of control of the Company within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. In connection with completion of the Acquisition, the Company has issued 210,000 common shares (the “Administrative Fee Shares“) to a consultant who assisted with the Acquisition.

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Joel Shacker
President

For further information, readers are encouraged to contact Joel Shacker, President, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Cannabis Expo London 2020 – Experience the Europe Canna Expo SPONSOR: Mota Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 4:36 PM on Monday, April 6th, 2020

SPONSOR: Mota is seeking to become a vertically integrated global CBD brand. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota. Combined total sales of almost $29,000,000 with a EBITDA of approximately 12.5% (2019) . Click Here for More Info

Mota large

With the current climate of social distancing and uncertainty, it’s no surprise that events have been forced to cancel or postpone left, right, and centre. Despite the disruption caused by the Coronavirus pandemic, some organisers are persevering with their plans – at least for the time being. One of those events is the Europe Canna Expo, set to take place in  London in July.

The Europe Canna Expo (ECE) is scheduled to make a return to London for a 2-day event on 26-27 July. Following the success of last year’s Europe CBD expo at the same location, the ECE will aim to bring together over 90 speakers and 125 exhibitors.

The Venue

The ECE is set to make a return to the London ExCel Centre in Canning Town East London. The event was held at the venue in July 2019, with an array of exhibitors and speakers. This year, the Europe Canna Expo is expected to be even bigger. However, uncertainty remains over the event.

The ExCel Centre is currently home to the temporary Nightingale hospital – the improvised care centre for victims of the Coronavirus. It remains unclear when the need for the venue will be over as the UK’s Coronavirus lockdown continues.

Exhibitors and Speakers

However, should the expo go on as planned, attendees will be spoilt for choice with speakers and professionals set to provide insights into the CBD, cannabinoid, and medical cannabis industries. In addition, the event will be present a huge number of exhibitors including a variety of manufacturers and businesses.

Speakers will include international experts showcasing senior-level insights and global scientific research in the CBD, cannabinoid and medical cannabis sectors. Organisers of the event expect that attendees will include consumers and businesses, as well as policymakers and press.

The event will provide an opportunity for global leading brands to showcase their products to thousands of attendees. From CBD drinks and chocolates to medicinal products, the Europe Canna Expo plans to present the most innovative international brands.

Event Schedule

The ECE organisers are yet to release a detailed schedule for the two-day cannabis expo. This may be due to the ongoing uncertainty surrounding the Coronavirus lockdown. For more information and up-to-date announcements, visit the ECE London website.

CLIENT FEATURE: Mota Ventures $MOTA.ca Continues to Define the European CBD Market $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 1:27 PM on Friday, April 3rd, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

RECENT HIGHLIGHTS

  • Immune Support Product Line Launched on March 14, 2020 Acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems, yielding an average initial order value of $189.00 USD.
  • First Class CBD brand achieved sales of Cdn$2,981,000 February 2020
  • Marketing efforts improved gross margins by 4.9% from January 2020 to February 2020.
  • February 2020 revenue represents an increase of 832% over the same period last year.
  • Plans to continue growth of First Class in the United States over the balance of 2020, as well as an expansion into the European market.

Formalized Joint Venture With Bevcanna Enterprises: Read More

Will share equal ownership in the Joint Venture and will be jointly responsible for developing and funding its operations

Company will provide manufacturing, marketing and distribution infrastructure in the European market.

Parties have determined an initial product launch and will provide further details on specific regions and timing once finalized

Formalized Collaboration for Sativida US Expansion Read More 

Acquired the intellectual property and trade names of Sativida

Unified Funding will provide assistance to Sativida with product sourcing, packaging, shipping, payment infrastructure and marketing

Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico

Entered into Licensing Agreement with Phenome One Read More

A privately held full-service live genetic and seed preservation cannabis company.

Mota will have full access to Canada’s largest live genetic cannabis library with over 350 cultivars

Mota will have the right to propagate, cultivate, harvest and process a minimum of 10 selected cultivars

2 World Class Brands:

#1. FIRST CLASS CBD: ONE OF THE LARGEST US BASED ONLINE RETAILERS OF CBD PRODUCTS

HIGHLIGHTS:

  • Leader in online CBD sales in North America
  • Crop to package model: US grown CBD hemp
  • Acquired at a 1.5 times revenue valuation
  • Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers
  • 2019 Sales of $19.2M USD/ EBITDA of 2.7M USD

  #2. SATIVIDA: ONLINE DIRECT TO CONSUMER RETAILER OF A VAST RANGE OF ORGANICE CBD OILS AND COSMETICS

HIGHLIGHTS:

  • Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom
  • Number one search-ranked online retailer in Spain and Mexico
  • Award winning product line known for its minimal heavy metal content and accurate CBD levels
  • 100% organic products

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value added products from its Latin American operations and distribute it both domestically and internationally. Mota has established distribution networks through the acquisition of First Class CBD in the United States and Sativida in Europe. Mota Ventures is also seeking to acquire revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

Hub on Agoracom

FULL DISCLOSURE: Mota Ventures. is an advertising client of AGORA Internet Relations Corp.

Mota Ventures $MOTA.ca Successful Immune Line Launch Signs Up Over 5,500 New Customers in 12 Days $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 5:06 PM on Friday, March 27th, 2020
  • Since March 14, 2020, Mota has acquired over 5,500 new customers
  • The product has yielded an average initial order value of $189.00 USD.

Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company” or “Mota“) is pleased to announce that since the launch of its Immune Support product line on March 14, 2020, the Company has acquired over 5,500 new customers seeking natural solutions to help support their family’s immune systems. The popularity of the primary product has yielded an average initial order value for immune support customers of $189.00 USD. Earlier this week the Company introduced an Immune CBD oil and Elderberry Gummies. The new Immune CBD product contains CBD, B3, B12, vitamin C and zinc and is made from 100% pure essential oils containing cinnamon leaf, lemon, clove bud, lime, eucalyptus, globulus, rosemary, peppermint, spearmint and oregano.

The Company has acquired over 50,000 new customer inquiries for Immune Support/CBD products since March 14, 2020. The Immune Support line is gaining interest from customers that historically were hesitant to purchase CBD, but are now interested in the Immune products and the potential anti-inflammatory benefits of CBD. In addition, traditional brick-and-mortar stores have been affected due to social distancing requirements, driving consumers to purchase online from the safety of their homes.

“The Immune Support product launch has been the most successful product launch in the history of our First Class brand. E-Commerce is a fast-moving sector, especially during these very unique times we are facing today. Our ability as a company to quickly develop and launch new products to meet market demand is a testament to our expertise. I am very excited by the reception we have received to date for our Immune Line of products. I project demand for the line will continue through Q2 and be a significant driver to our growth for 2020,” stated Ryan Hoggan, CEO of the Company.

Additionally, the Company has entered into a 12 month programmatic digital advertising campaign with Native Ads, Inc. for a total cost of C$80,000; consisting of C$72,000 for digital advertising, paid distribution, and media buying over the campaign period and, C$8,000 for content creation, consulting, managed services and management fees over the course of the campaign period. Native Ads is a full-service advertising agency, that owns and operates a proprietary ad exchange with over 80 integrated SSPs (supply side platforms) resulting in access to 3-7 billion daily North American ad impressions. Neither Native Ads nor any of its directors and officers own any securities of the Company.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Mota Ventures $MOTA.ca Moves Forward with Its Acquisition of Spanish CBD Company Sativida $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 8:51 AM on Thursday, March 26th, 2020

Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTCPINK:PEMTF) (the “Company” or “Mota“) is pleased to announce that further to its January 10, 2020 news release, it has now acquired the intellectual property and trade names of Sativida from Sativida OU (Estonia). The Company will license both back to Sativida OU’s subsidiary, VIDA BCN LABS S.L. (collectively with Sativida OU, “Sativida“) in exchange for a royalty associated with the gross revenues generated by Sativida.

Sativida is an arms’-length producer and online retailer of cannabidiol (“CBD“) and branded CBD products in various jurisdictions in Europe, including Spain, Portugal, Austria, Germany, France and the United Kingdom. Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is in the process of expanding its distribution network internationally to include the United States. Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico, and intends to continue its expansion into other countries in Europe and Latin America.

Through Mota, Sativida has an agreement with Unified Funding, LLC (“Unified“) for the expansion of the brand into the United States. Unified will provide assistance to Sativida with product sourcing, packaging, shipping, payment infrastructure and marketing in the United States. Unified Funding is an e-Commerce and technology company focused on serving U.S.-based and international consumers in the CBD and natural health products market. Powered by its proprietary technology platform, Unified has created an e-Commerce ecosystem to scale its brands through data analysis, strategic customer acquisition and supply chain management. Since June 2015, Unified has generated a database of over 4.5 million consumers and has facilitated over US$200 million in consumer transactions from more than one million paying customers.

“I am very excited to announce the acquisition of the Sativida brand. This gives Mota immediate entry into the European market and will be a building block for our planned European expansion. Mota’s U.S. operation, First Class CBD, is set to enter the European market and we expect the acquisition of the Sativida brand to expedite this expansion. Furthermore, our partnership with Unified Funding, LLC, the e-Commerce platform behind the success of First Class CBD, will allow us to bring the Sativida brand to the U.S. market as well,” stated Ryan Hoggan, CEO of the Company.

Noah Laith, founder of Sativida, commented, “Joining Mota is a major step for Sativida that will provide access to the capital, connections and infrastructure necessary to grow our business in Europe and internationally.”

Pursuant to the previously announced binding agreement with Sativida dated January 9, 2020 (the “Transaction Agreement“), the Company was granted the right to acquire Sativida in stages (the “Transaction“), at the discretion of the Company, as certain corporate and intellectual property registrations were completed. To accomplish this, the Company set up a wholly-owned Spanish subsidiary (“Spanish Subco“) and coordinated the registration of various intellectual property and trade names associated with business operations of Sativida.

The Company, through Spanish Subco, has now completed the acquisition of the intellectual property and trade names of Sativida in Spain, and will license both back to Sativida in exchange for a royalty associated with the gross revenues generated by Sativida. Pursuant to the Transaction Agreement, the Company also holds the right to acquire, through Spanish Subco, all of the outstanding share capital of Sativida at any time for no additional consideration.

Consideration for the Transaction is made up of an initial component of €2,000,001 (the “Consideration“) and an earn-out component made up of three milestone payments based upon the revenue of Sativida (each, a “Milestone Payment“). The Consideration was paid in 5,496,221 common shares of the Company (the “Consideration Shares“) at a deemed price of $0.5689 per share. Each Milestone Payment will be based on a 400% multiple of Sativida’s revenue until the aggregate of the Initial Consideration and Milestone Payments reaches €4,000,000, at which point the multiple will be reduced to 100%. In no event will the combined Milestone Payments and the value of the Initial Consideration exceed €15,000,000. Payment of the Milestone Payments will be satisfied by the Company issuing common shares (“Milestone Shares“) to Sativida. The total number of Milestone Shares issuable to Sativida will be determined by dividing the amount due by the volume weighted average closing price of the Company’s common shares on the Canadian Securities Exchange in the ten trading days prior to the day that the Milestone Payment is due.

The Consideration Shares and the Milestone Shares will each be subject to a 36-month pooling arrangement such that 10% of the Consideration Shares, or the Milestone Shares, as applicable, will be released from escrow on upon their issuance, with an additional 15% being released every six-months thereafter until all Consideration Shares or all Milestone Shares, as applicable, are released.

As part of the Transaction, Mota Ventures will enter into employment contracts with certain employees of Sativida and will provide an option pool that may be divided among the employees of Sativida equal to €60,000 in stock options of Mota Ventures for every €1,000,000 in revenue that Sativida earns, subject to certain conditions. Additionally, Mota Ventures has paid a 10% finder’s fee based on the total value of the Consideration Shares (528,072 common shares) to certain finders that assisted in introducing the Transaction to the parties as well as a 2% administrative success fee based on the total value of the Consideration Shares (105,614 common shares) to a consultant who assisted in the administration of the transaction.

The Company and Sativida are at arms’-length. The Transaction is not expected to result in a “reverse-takeover” or “fundamental change” for the Company under the policies of the Canadian Securities Exchange, or result in the creation of any new insider or control person of the Company. No changes to the board of directors, or management, of the Company are contemplated in connection with the Transaction.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

About Sativida

Sativida is a producer and online retailer of CBD and branded CBD products in various jurisdictions in Europe, including Spain and the United Kingdom. Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is currently expanding its distribution network internationally. For more information on Sativida, readers are encouraged to review their website at www.sativida.es.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Mota Ventures $MOTA.ca Launching Immune Support CBD Line; Pure Herbal Immunity Blend Acquiring 1,838 New Customers Within a Week APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 12:13 PM on Monday, March 23rd, 2020

Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC:PEMTF) (the “Company” or “Mota”) is pleased to announce that since the launch of the Pure Herbal Immunity Blend under the First Class brand on March 14th, 2020, it has had an exceptional reception, acquiring 1,838 new customers.

The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. Due to customer demand for pure and efficacious products to support the immune system, the Company will be launching an Immune CBD oil, along with an Elderberry Gummy product on Monday, March 23rd. The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Based on the success of the launch, First Class will be increasing marketing efforts throughout the US.

The Company plans to offer similar immune products in Europe through its Sativida brand, which currently retails product in various jurisdictions in Europe, including Spain, Portugal, Austria, Germany, France and the United Kingdom.

The Company anticipates the completion of the Sativida transaction in the next seven days. Further to its January 10, 2020 news release, the Company will acquire the intellectual property and trade names of Sativida from VIDA BCN LABS SL (Spain) and Sativida OU (Estonia) (collectively, “Sativida”). The Company will license both back to Sativida in exchange for a royalty associated with the gross revenues generated by Sativida.

“As our customers around the globe face challenges in their daily lives, we are working diligently to provide products to help families with natural health needs. Our supply chain is operating uninterrupted and we are quickly working to expand our immune support product line. We stand ready to continue to adapt to market changes and innovate new products to take advantage of the numerous opportunities ahead”, states Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

About Sativida

Sativida is a producer and online retailer of CBD and branded CBD products in various jurisdictions in Europe, including Spain and the United Kingdom. Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is currently expanding its distribution network internationally. For more information on Sativida, readers are encouraged to review their website, www.sativida.es.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected]or www.motaventuresco.com

CLIENT FEATURE: Mota Ventures Announces 832% Growth in February 2020 over the Same Period Last Year $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 12:51 PM on Thursday, March 19th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564664/hub/MOTA_Large.png

RECENT HIGHLIGHTS

  • First Class CBD brand achieved sales of Cdn$2,981,000 February 2020
  • Marketing efforts improved gross margins by 4.9% from January 2020 to February 2020.
  • February 2020 represents an increase of 832% over the same period last year.
  • Plans to continue growth of First Class in the United States over the balance of 2020, as well as an expansion into the European market.
  • Formalized Joint Venture With Bevcanna Enterprises: Read More
    • Will share equal ownership in the Joint Venture and will be jointly responsible for developing and funding its operations
    • Company will provide manufacturing, marketing and distribution infrastructure in the European market.
    • Parties have determined an initial product launch and will provide further details on specific regions and timing once finalize
  • Announced Collaboration for Sativida US Expansion Read More 
    • Unified Funding will provide assistance to Sativida with product sourcing, packaging, shipping, payment infrastructure and marketing
    • Sativida has become the number one search-ranked online retailer of CBD products in Spain and Mexico
  • Entered into Licensing Agreement with Phenome One Read More
    • A privately held full-service live genetic and seed preservation cannabis company.
    • Mota will have full access to Canada’s largest live genetic cannabis library with over 350 cultivars
    • Mota will have the right to propagate, cultivate, harvest and process a minimum of 10 selected cultivars

2 World Class Brands:

#1. FIRST CLASS CBD: ONE OF THE LARGEST US BASED ONLINE RETAILERS OF CBD PRODUCTS

HIGHLIGHTS:

  • Leader in online CBD sales in North America
  • Crop to package model: US grown CBD hemp
  • Acquired at a 1.5 times revenue valuation
  • Current customer base 142,000 customers -with additional leads of over 424,000 potential new customers
  • 2019 Sales of $19.2M USD/ EBITDA of 2.7M USD

  #2. SATIVIDA: ONLINE DIRECT TO CONSUMER RETAILER OF A VAST RANGE OF ORGANICE CBD OILS AND COSMETICS

HIGHLIGHTS:

  • Current distributor of CBD products in Spain, Portugal, Austria, Germany, France and the United Kingdom
  • Number one search-ranked online retailer in Spain and Mexico
  • Award winning product line known for its minimal heavy metal content and accurate CBD levels
  • 100% organic products

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value added products from its Latin American operations and distribute it both domestically and internationally. Mota has established distribution networks through the acquisition of First Class CBD in the United States and Sativida in Europe. Mota Ventures is also seeking to acquire revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

Hub on Agoracom

FULL DISCLOSURE: Mota Ventures. is an advertising client of AGORA Internet Relations Corp.